Clinical Trial Update: Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the use of autofluorescence and indocyanine green to prevent hypocalcemia after thyroidectomy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism Postprocedural
• Thyroid Disease

Snippet

Sponsor: Onze Lieve Vrouw Hospital | Conditions: Thyroid Disease, Hypoparathyroidism Postprocedural | Phase 3 | Status: RECRUITING